GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eco Animal Health Group PLC (LSE:EAH) » Definitions » Debt-to-EBITDA

Eco Animal Health Group (LSE:EAH) Debt-to-EBITDA : 2.84 (As of Sep. 2023)


View and export this data going back to 1995. Start your Free Trial

What is Eco Animal Health Group Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Eco Animal Health Group's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was £0.93 Mil. Eco Animal Health Group's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was £3.20 Mil. Eco Animal Health Group's annualized EBITDA for the quarter that ended in Sep. 2023 was £1.46 Mil. Eco Animal Health Group's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2023 was 2.84.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Eco Animal Health Group's Debt-to-EBITDA or its related term are showing as below:

LSE:EAH' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.07   Med: 0.4   Max: 1.01
Current: 1.01

During the past 13 years, the highest Debt-to-EBITDA Ratio of Eco Animal Health Group was 1.01. The lowest was 0.07. And the median was 0.40.

LSE:EAH's Debt-to-EBITDA is ranked better than
62.42% of 660 companies
in the Drug Manufacturers industry
Industry Median: 1.69 vs LSE:EAH: 1.01

Eco Animal Health Group Debt-to-EBITDA Historical Data

The historical data trend for Eco Animal Health Group's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eco Animal Health Group Debt-to-EBITDA Chart

Eco Animal Health Group Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.14 0.49 0.07 0.52 0.60

Eco Animal Health Group Semi-Annual Data
Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.22 2.79 0.22 0.67 2.84

Competitive Comparison of Eco Animal Health Group's Debt-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Eco Animal Health Group's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eco Animal Health Group's Debt-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Eco Animal Health Group's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Eco Animal Health Group's Debt-to-EBITDA falls into.



Eco Animal Health Group Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Eco Animal Health Group's Debt-to-EBITDA for the fiscal year that ended in Mar. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.884 + 3.596) / 7.447
=0.60

Eco Animal Health Group's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.934 + 3.204) / 1.456
=2.84

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is two times the quarterly (Sep. 2023) EBITDA data.


Eco Animal Health Group  (LSE:EAH) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Eco Animal Health Group Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Eco Animal Health Group's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Eco Animal Health Group (LSE:EAH) Business Description

Traded in Other Exchanges
N/A
Address
78 Coombe Road, New Malden, London, Surrey, GBR, KT3 4QS
Eco Animal Health Group PLC is engaged in the manufacture and marketing of animal health products. The company's product portfolio includes Aivlosin - macrolide antibiotic for the treatment of respiratory and enteric diseases in pigs and poultry; Ecomectin, Eco heart, Ecotraz, and Ecomintic for treatment and prevention of parasites in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infections in pigs, poultry and cattle. The geographical segments of the company include Corporate/UK, China & Japan, North America, South & South East Asia, Latin America, Europe, and the Rest of the World.

Eco Animal Health Group (LSE:EAH) Headlines

No Headlines